Cargando…

5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells

Despite high cure rates, about 20% of patients with advanced germ cell tumors (GCTs) fail cisplatin-based chemotherapy. High levels of DNA methylation have been identified in GCTs and linked to cisplatin resistance. Here, we examined the effects of DNA hypomethylating 5-azacitidine (5-aza) on two em...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oing, Christoph, Verem, Izudin, Mansour, Wael Y., Bokemeyer, Carsten, Dyshlovoy, Sergey, Honecker, Friedemann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337423/ https://www.ncbi.nlm.nih.gov/pubmed/30577584 http://dx.doi.org/10.3390/ijms20010021

Ejemplares similares

Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
por: Port, Matthias, et al.
Publicado: (2011)

Distinct Proteomic Profile of Spermatozoa from Men with Seminomatous and Non-Seminomatous Testicular Germ Cell Tumors
por: Panner Selvam, Manesh Kumar, et al.
Publicado: (2020)

Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

The management of low-stage non-seminomatous germ cell tumors
por: Lim, Louise, et al.
Publicado: (2012)

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
por: Gerl, A., et al.
Publicado: (1996)

The changing role of surgery in metastatic non-seminomatous germ cell tumour.
por: Cassidy, J., et al.
Publicado: (1992)

Marine Compounds and Cancer: Where Do We Stand?
por: Dyshlovoy, Sergey A., et al.
Publicado: (2015)

Marine Compounds and Cancer: 2017 Updates
por: Dyshlovoy, Sergey A., et al.
Publicado: (2018)

Marine Compounds and Autophagy: Beginning of a New Era
por: Dyshlovoy, Sergey A., et al.
Publicado: (2018)

Marine Drugs Acting as Autophagy Modulators
por: Dyshlovoy, Sergey A., et al.
Publicado: (2020)

Marine Compounds and Cancer: The First Two Decades of XXI Century
por: Dyshlovoy, Sergey A., et al.
Publicado: (2019)

Marine Compounds and Cancer: Updates 2020
por: Dyshlovoy, Sergey A., et al.
Publicado: (2020)

Marine Compounds and Cancer: Updates 2022
por: Dyshlovoy, Sergey A., et al.
Publicado: (2022)

Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
por: Bono, J S de, et al.
Publicado: (2000)

The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.
por: Harding, M., et al.
Publicado: (1995)

Non-Seminomatous Germ Cell Tumor Metastasis to the Jaw: An Imaging Case Report
por: Siverino, Rita Olivia, et al.
Publicado: (2016)

Non-Seminomatous Germ Cell Tumor Presenting with Superior Vena Cava Syndrome
por: Soriano, Paolo K., et al.
Publicado: (2017)

Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
por: Seckl, M. J., et al.
Publicado: (1990)

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
por: Raghavan, D., et al.
Publicado: (1982)

Urethral metastasis from non-seminomatous germ cell tumor: a case report
por: Agarwal, Vijay, et al.
Publicado: (2011)

Bone marrow metastasis in a patient with non‐seminomatous testicular germ cell tumor
por: Ueda, Takashi, et al.
Publicado: (2022)

The component of the m(6)A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2021)

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2022)

Cisplatin-induced posterior reversible encephalopathy syndrome and successful re-treatment in a patient with non-seminomatous germ cell tumor: a case report
por: Zahir, Muhammad Nauman, et al.
Publicado: (2012)

Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor
por: Xavier, Rosana, et al.
Publicado: (2020)

Brain angiometastasis from a non-seminomatous germ cell tumor: A case report
por: Monroy-Sosa, Alejandro, et al.
Publicado: (2017)

SAT-218 Metastatic Non Seminomatous Germ Cell Tumor Masquerading as Bilateral Adrenal Masses
por: Baral, Neelam, et al.
Publicado: (2020)

Approach to chemotherapy for high-risk, stage 1, non-seminomatous, germ cell testicular tumors
por: Anand, Madhur
Publicado: (2021)

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
por: Dearnaley, D P, et al.
Publicado: (2005)

The use of cisplatin in patients after kidney transplantation with chronic renal insufficiency: Is the benefit higher than potential risks in therapy of non-seminomatous germ cell tumors?
por: Pokrivcak, Tomas, et al.
Publicado: (2021)

Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour
por: Johnson, P J, et al.
Publicado: (1999)

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
por: Fizazi, K, et al.
Publicado: (2002)

Two Cases of Cerebral Sinus Venous Thrombosis Following Chemotherapy for Non-Seminomatous Germ Cell Tumor
por: Papet, C., et al.
Publicado: (2011)

Seminomatous Extragonadal Germ Cell Tumor with Complete Obstruction of the Superior Vena Cava Responding to Intensive Chemotherapy
por: Moritoki, Yoshinobu, et al.
Publicado: (2011)

Non-seminomatous germ cell tumor with bone metastasis only at diagnosis: A rare clinical presentation
por: Biebighauser, K.C., et al.
Publicado: (2017)

Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors
por: Green, Daniel B., et al.
Publicado: (2021)

Mycalamide A Shows Cytotoxic Properties and Prevents EGF-Induced Neoplastic Transformation through Inhibition of Nuclear Factors
por: Dyshlovoy, Sergey A., et al.
Publicado: (2012)

Aaptamines from the Marine Sponge Aaptos sp. Display Anticancer Activities in Human Cancer Cell Lines and Modulate AP-1-, NF-κB-, and p53-Dependent Transcriptional Activity in Mouse JB6 Cl41 Cells
por: Dyshlovoy, Sergey A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jjnq3g0ml49piclvreqtla8jtl